Process View
The chemical reactions and pathways resulting in the formation of cytokines, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cytokine biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.994 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.980 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.974 | Human | |
| CD80 | CD80 molecule | 0.947 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.939 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.929 | Mouse | |
| IL1R1 | interleukin 1 receptor, type I | 0.887 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.877 | Mouse | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.868 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.829 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.821 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.818 | Human | |
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.807 | Mouse | |
| SYK | spleen tyrosine kinase | 0.773 | Mouse | |
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.759 | ||
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.759 | Human | |
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.748 | ||
| IL1B | interleukin 1, beta | 0.721 | ||
| CD86 | CD86 molecule | 0.693 | Human | |
| LCK | lymphocyte-specific protein tyrosine kinase | 0.666 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.632 | ||
| BTN3A3 | butyrophilin, subfamily 3, member A3 | 0.631 | Human | |
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.629 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.547 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.533 | Mouse | |
| BTN3A2 | butyrophilin, subfamily 3, member A2 | 0.526 | Human | |
| TRAF1 | TNF receptor-associated factor 1 | 0.512 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.507 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.474 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.471 | ||
| IL2RB | interleukin 2 receptor, beta | 0.424 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.393 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.387 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.380 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.366 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.361 | ||
| TLR4 | toll-like receptor 4 | 0.361 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.355 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.353 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.351 | Mouse | |
| LAT | linker for activation of T cells | 0.346 | ||
| IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.342 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.328 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.306 | Human | |
| BCL3 | B-cell CLL/lymphoma 3 | 0.279 | ||
| IL8 | interleukin 8 | 0.278 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.260 | Mouse | |
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.247 | ||
| CD2 | CD2 molecule | 0.245 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.240 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.214 | ||
| CREBBP | CREB binding protein | 0.207 | ||
| CD247 | CD247 molecule | 0.202 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.197 | Human | |
| GNLY | granulysin | 0.192 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.166 | ||
| JUN | jun proto-oncogene | 0.161 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.160 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.156 | ||
| BLNK | B-cell linker | 0.148 | ||
| IRF7 | interferon regulatory factor 7 | 0.148 | Human Mouse | |
| INSR | insulin receptor | 0.147 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.139 | ||
| CD28 | CD28 molecule | 0.138 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.137 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.136 | ||
| JUNB | jun B proto-oncogene | 0.134 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.134 | ||
| EPOR | erythropoietin receptor | 0.133 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.131 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.130 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.128 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.121 | Human | |
| TRADD | TNFRSF1A-associated via death domain | 0.121 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.120 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.115 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.111 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.109 | Human | |
| CD48 | CD48 molecule | 0.109 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.108 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.105 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.104 | ||
| GRAP2 | GRB2-related adaptor protein 2 | 0.103 | ||
| SLAMF7 | SLAM family member 7 | 0.102 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.101 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.097 | ||
| CRYAB | crystallin, alpha B | 0.097 | ||
| IL4R | interleukin 4 receptor | 0.094 | ||
| IRF4 | interferon regulatory factor 4 | 0.092 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.089 | ||
| CD1C | CD1c molecule | 0.088 | ||
| SH2D1A | SH2 domain containing 1A | 0.088 | ||
| JAK2 | Janus kinase 2 | 0.087 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.083 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.080 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.077 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.077 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.077 | Mouse | |
| APOA1 | apolipoprotein A-I | 0.077 | ||
| SQSTM1 | sequestosome 1 | 0.077 | ||
| IL6R | interleukin 6 receptor | 0.076 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.076 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.074 | Mouse | |
| GSK3B | glycogen synthase kinase 3 beta | 0.074 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.072 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.071 | Human | |
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.070 | ||
| IRF8 | interferon regulatory factor 8 | 0.062 | Human | |
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.062 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.061 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.061 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.059 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.058 | ||
| FPR1 | formyl peptide receptor 1 | 0.058 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.058 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.058 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.057 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.056 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.054 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.054 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.054 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.054 | ||
| PRF1 | perforin 1 (pore forming protein) | 0.053 | ||
| HK3 | hexokinase 3 (white cell) | 0.052 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.052 | Human | |
| EGR1 | early growth response 1 | 0.051 | ||
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.051 | ||
| TLR2 | toll-like receptor 2 | 0.051 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.050 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.050 | ||
| CDHR2 | cadherin-related family member 2 | 0.050 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.050 | ||
| IFNG | interferon, gamma | 0.048 | ||
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 0.047 | ||
| MAFB | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | 0.047 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.046 | ||
| CTSG | cathepsin G | 0.045 | Human | |
| LY86 | lymphocyte antigen 86 | 0.044 | ||
| HDC | histidine decarboxylase | 0.044 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.044 | ||
| PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 0.044 | ||
| FCAR | Fc fragment of IgA, receptor for | 0.043 | Human | |
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.043 | ||
| IER2 | immediate early response 2 | 0.043 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.042 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.042 | Mouse | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.042 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.042 | ||
| IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.041 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.041 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.041 | ||
| ENO2 | enolase 2 (gamma, neuronal) | 0.040 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.040 | ||
| ATF3 | activating transcription factor 3 | 0.040 | ||
| BCL2A1 | BCL2-related protein A1 | 0.040 | ||
| GPR18 | G protein-coupled receptor 18 | 0.039 | ||
| IRF1 | interferon regulatory factor 1 | 0.039 | Human Mouse | |
| TNF | tumor necrosis factor | 0.039 | ||
| CFP | complement factor properdin | 0.039 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.038 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.038 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.038 | ||
| MPO | myeloperoxidase | 0.037 | ||
| TRAT1 | T cell receptor associated transmembrane adaptor 1 | 0.037 | ||
| FGL2 | fibrinogen-like 2 | 0.037 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.037 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.036 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.036 | Mouse | |
| TGFB1 | transforming growth factor, beta 1 | 0.036 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.036 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.036 | ||
| PTAFR | platelet-activating factor receptor | 0.035 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.035 | Human | |
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.035 | ||
| TRIM21 | tripartite motif containing 21 | 0.035 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.034 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.034 | ||
| CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | 0.034 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.034 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.034 | ||
| SMAD3 | SMAD family member 3 | 0.034 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 0.034 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.034 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.033 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.033 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.033 | ||
| CD38 | CD38 molecule | 0.033 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.033 | ||
| LILRA5 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | 0.033 | Human | |
| A2M | alpha-2-macroglobulin | 0.032 | ||
| ATF5 | activating transcription factor 5 | 0.032 | ||
| AIF1 | allograft inflammatory factor 1 | 0.032 | ||
| ELANE | elastase, neutrophil expressed | 0.032 | ||
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | 0.032 | Human | |
| PRDM1 | PR domain containing 1, with ZNF domain | 0.032 | ||
| ASRGL1 | asparaginase like 1 | 0.031 | ||
| FPR2 | formyl peptide receptor 2 | 0.031 | ||
| CD180 | CD180 molecule | 0.031 | Human | |
| CTSW | cathepsin W | 0.031 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.030 | Human | |
| EHD1 | EH-domain containing 1 | 0.030 | ||
| RNF19B | ring finger protein 19B | 0.029 | ||
| GPR65 | G protein-coupled receptor 65 | 0.029 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.029 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.029 | ||
| S100A12 | S100 calcium binding protein A12 | 0.029 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.028 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.028 | ||
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.028 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.028 | ||
| IL10 | interleukin 10 | 0.028 | Rat | |
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.027 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.027 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.027 | ||
| CST7 | cystatin F (leukocystatin) | 0.027 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.027 | Human | |
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.026 | ||
| IRF2 | interferon regulatory factor 2 | 0.026 | Human | |
| AZI2 | 5-azacytidine induced 2 | 0.026 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.026 | ||
| PRKCZ | protein kinase C, zeta | 0.026 | ||
| GHR | growth hormone receptor | 0.026 | ||
| UBA7 | ubiquitin-like modifier activating enzyme 7 | 0.026 | ||
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0.026 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.025 | ||
| SESN2 | sestrin 2 | 0.025 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.025 | ||
| BIN2 | bridging integrator 2 | 0.025 | ||
| C9orf89 | chromosome 9 open reading frame 89 | 0.025 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.025 | ||
| ICOS | inducible T-cell co-stimulator | 0.025 | ||
| FOSL1 | FOS-like antigen 1 | 0.025 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.025 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.025 | ||
| SH2D2A | SH2 domain containing 2A | 0.024 | ||
| VNN2 | vanin 2 | 0.024 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.024 | ||
| HCP5 | HLA complex P5 | 0.024 | ||
| IER5 | immediate early response 5 | 0.024 | ||
| CD72 | CD72 molecule | 0.023 | ||
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.023 | Human | |
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.023 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.023 | ||
| TICAM1 | toll-like receptor adaptor molecule 1 | 0.023 | Mouse | |
| IGSF6 | immunoglobulin superfamily, member 6 | 0.023 | ||
| RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.023 | ||
| CD300C | CD300c molecule | 0.023 | ||
| CMA1 | chymase 1, mast cell | 0.023 | ||
| CD5 | CD5 molecule | 0.023 | ||
| GIMAP5 | GTPase, IMAP family member 5 | 0.023 | ||
| LY9 | lymphocyte antigen 9 | 0.022 | ||
| IL21R | interleukin 21 receptor | 0.022 | ||
| GARS | glycyl-tRNA synthetase | 0.022 | ||
| PRTN3 | proteinase 3 | 0.022 | Human | |
| CD33 | CD33 molecule | 0.022 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.022 | ||
| HCK | hemopoietic cell kinase | 0.022 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.022 | Human | |
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.022 | ||
| CTBP1 | C-terminal binding protein 1 | 0.022 | ||
| GBP5 | guanylate binding protein 5 | 0.022 | ||
| MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.022 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.022 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.022 | ||
| ADM | adrenomedullin | 0.021 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.021 | ||
| HSPB8 | heat shock 22kDa protein 8 | 0.021 | ||
| GPR171 | G protein-coupled receptor 171 | 0.021 | ||
| CD84 | CD84 molecule | 0.021 | ||
| TLR6 | toll-like receptor 6 | 0.021 | Human | |
| SP1 | Sp1 transcription factor | 0.021 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.021 | ||
| FST | follistatin | 0.021 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.020 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.020 | ||
| BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.020 | Human | |
| CD40LG | CD40 ligand | 0.020 | ||
| SLA | Src-like-adaptor | 0.020 | ||
| IER3 | immediate early response 3 | 0.020 | ||
| DNTT | deoxynucleotidyltransferase, terminal | 0.020 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.020 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.020 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.019 | ||
| RUNX2 | runt-related transcription factor 2 | 0.019 | ||
| RPGRIP1 | retinitis pigmentosa GTPase regulator interacting protein 1 | 0.019 | ||
| BPI | bactericidal/permeability-increasing protein | 0.019 | ||
| IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 0.019 | ||
| RHOB | ras homolog gene family, member B | 0.019 | ||
| DNTTIP2 | deoxynucleotidyltransferase, terminal, interacting protein 2 | 0.019 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.019 | Mouse | |
| EBI3 | Epstein-Barr virus induced 3 | 0.019 | ||
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.019 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.019 | ||
| TIFA | TRAF-interacting protein with forkhead-associated domain | 0.019 | ||
| AZU1 | azurocidin 1 | 0.019 | ||
| TANK | TRAF family member-associated NFKB activator | 0.019 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.018 | ||
| DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.018 | ||
| EMR3 | egf-like module containing, mucin-like, hormone receptor-like 3 | 0.018 | ||
| MXD1 | MAX dimerization protein 1 | 0.018 | ||
| TYMP | thymidine phosphorylase | 0.018 | ||
| FOSL2 | FOS-like antigen 2 | 0.018 | ||
| CD7 | CD7 molecule | 0.018 | ||
| CARS | cysteinyl-tRNA synthetase | 0.018 | ||
| ZBTB48 | zinc finger and BTB domain containing 48 | 0.018 | ||
| CD1D | CD1d molecule | 0.018 | Mouse | |
| CLC | Charcot-Leyden crystal protein | 0.018 | ||
| MTF2 | metal response element binding transcription factor 2 | 0.018 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.018 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.018 | ||
| GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.018 | Human | |
| AQP9 | aquaporin 9 | 0.018 | ||
| JAK3 | Janus kinase 3 | 0.018 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.018 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.018 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.017 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.017 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.017 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.017 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.017 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.017 | ||
| DEFA4 | defensin, alpha 4, corticostatin | 0.017 | ||
| CRYAA | crystallin, alpha A | 0.017 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.017 | Mouse | |
| TFEC | transcription factor EC | 0.017 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.017 | ||
| MARCO | macrophage receptor with collagenous structure | 0.017 | ||
| FFAR2 | free fatty acid receptor 2 | 0.017 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.017 | Human | |
| IFNB1 | interferon, beta 1, fibroblast | 0.017 | ||
| RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 0.017 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.017 | ||
| CCNL1 | cyclin L1 | 0.017 | ||
| KLRG1 | killer cell lectin-like receptor subfamily G, member 1 | 0.016 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.016 | ||
| CD83 | CD83 molecule | 0.016 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.016 | ||
| PIM1 | pim-1 oncogene | 0.016 | ||
| CD300A | CD300a molecule | 0.016 | ||
| PLEK | pleckstrin | 0.016 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.016 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.016 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.016 | ||
| SERTAD1 | SERTA domain containing 1 | 0.016 | ||
| TARP | TCR gamma alternate reading frame protein | 0.016 | ||
| PYDC2 | pyrin domain containing 2 | 0.016 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.016 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.016 | ||
| TRIB3 | tribbles homolog 3 (Drosophila) | 0.016 | Human | |
| CRIP1 | cysteine-rich protein 1 (intestinal) | 0.016 | ||
| RETN | resistin | 0.016 | ||
| PYCARD | PYD and CARD domain containing | 0.016 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.016 | ||
| GZMM | granzyme M (lymphocyte met-ase 1) | 0.015 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.015 | ||
| IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | 0.015 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.015 | ||
| RUNX3 | runt-related transcription factor 3 | 0.015 | ||
| HAMP | hepcidin antimicrobial peptide | 0.015 | ||
| IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0.015 | ||
| BST1 | bone marrow stromal cell antigen 1 | 0.015 | ||
| KIAA1274 | KIAA1274 | 0.015 | ||
| HP | haptoglobin | 0.015 | ||
| CSK | c-src tyrosine kinase | 0.015 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.015 | ||
| ALB | albumin | 0.015 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.015 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.015 | Mouse | |
| CYTH4 | cytohesin 4 | 0.015 | ||
| LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | 0.015 | Human | |
| RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.015 | ||
| P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 0.015 | ||
| INHBA | inhibin, beta A | 0.015 | Human | |
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.015 | ||
| CH25H | cholesterol 25-hydroxylase | 0.015 | ||
| BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | 0.015 | ||
| TBX21 | T-box 21 | 0.015 | ||
| IFI35 | interferon-induced protein 35 | 0.015 | ||
| TRAF7 | TNF receptor-associated factor 7 | 0.015 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.015 | Rat | |
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.014 | ||
| ASNS | asparagine synthetase (glutamine-hydrolyzing) | 0.014 | ||
| TPSAB1 | tryptase alpha/beta 1 | 0.014 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.014 | ||
| IRS1 | insulin receptor substrate 1 | 0.014 | ||
| MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) | 0.014 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.014 | ||
| C13orf18 | chromosome 13 open reading frame 18 | 0.014 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.014 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.014 | ||
| IL7R | interleukin 7 receptor | 0.014 | ||
| TYROBP | TYRO protein tyrosine kinase binding protein | 0.014 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.014 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.014 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.014 | ||
| NMI | N-myc (and STAT) interactor | 0.014 | ||
| PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 0.014 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.014 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.014 | ||
| ARG1 | arginase, liver | 0.014 | ||
| FLT3 | fms-related tyrosine kinase 3 | 0.014 | ||
| IRAK3 | interleukin-1 receptor-associated kinase 3 | 0.014 | ||
| GPR132 | G protein-coupled receptor 132 | 0.014 | ||
| CPA3 | carboxypeptidase A3 (mast cell) | 0.014 | ||
| SERPINB10 | serpin peptidase inhibitor, clade B (ovalbumin), member 10 | 0.014 | ||
| ETV7 | ets variant 7 | 0.014 | ||
| ITGB7 | integrin, beta 7 | 0.013 | ||
| DBP | D site of albumin promoter (albumin D-box) binding protein | 0.013 | ||
| MARCH1 | membrane-associated ring finger (C3HC4) 1 | 0.013 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.013 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.013 | ||
| SLC9A3 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 | 0.013 | ||
| DAPK3 | death-associated protein kinase 3 | 0.013 | ||
| HMHA1 | histocompatibility (minor) HA-1 | 0.013 | ||
| LRMP | lymphoid-restricted membrane protein | 0.013 | ||
| IL21 | interleukin 21 | 0.013 | ||
| TLR7 | toll-like receptor 7 | 0.013 | ||
| CD96 | CD96 molecule | 0.013 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.013 | ||
| GFI1 | growth factor independent 1 transcription repressor | 0.013 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.013 | ||
| FLT3LG | fms-related tyrosine kinase 3 ligand | 0.013 | ||
| KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.013 | ||
| VNN1 | vanin 1 | 0.013 | ||
| HBD | hemoglobin, delta | 0.013 | ||
| DENND2D | DENN/MADD domain containing 2D | 0.013 | ||
| RUNX1 | runt-related transcription factor 1 | 0.013 | ||
| GPR84 | G protein-coupled receptor 84 | 0.013 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.013 | ||
| LAIR2 | leukocyte-associated immunoglobulin-like receptor 2 | 0.013 | Human | |
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.013 | ||
| MYO1F | myosin IF | 0.013 | ||
| VEGFA | vascular endothelial growth factor A | 0.013 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.013 | ||
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.013 | ||
| KLF6 | Kruppel-like factor 6 | 0.013 | Human | |
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.013 | ||
| TRANK1 | tetratricopeptide repeat and ankyrin repeat containing 1 | 0.013 | ||
| CD27 | CD27 molecule | 0.013 | ||
| IL13 | interleukin 13 | 0.013 | ||
| CD69 | CD69 molecule | 0.013 | ||
| GPR109B | G protein-coupled receptor 109B | 0.012 | ||
| MARS | methionyl-tRNA synthetase | 0.012 | ||
| PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 0.012 | Human | |
| STX11 | syntaxin 11 | 0.012 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.012 | ||
| CD6 | CD6 molecule | 0.012 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.012 | ||
| ZFP36L2 | zinc finger protein 36, C3H type-like 2 | 0.012 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.012 | ||
| RARRES3 | retinoic acid receptor responder (tazarotene induced) 3 | 0.012 | ||
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.012 | ||
| NKG7 | natural killer cell group 7 sequence | 0.012 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.012 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.012 | ||
| RNASE6 | ribonuclease, RNase A family, k6 | 0.012 | ||
| ALAS2 | aminolevulinate, delta-, synthase 2 | 0.012 | ||
| RHOH | ras homolog gene family, member H | 0.012 | ||
| NLRC5 | NLR family, CARD domain containing 5 | 0.012 | Human | |
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.012 | ||
| CD209 | CD209 molecule | 0.012 | Mouse | |
| G0S2 | G0/G1switch 2 | 0.012 | ||
| CD163 | CD163 molecule | 0.012 | ||
| POU2F2 | POU class 2 homeobox 2 | 0.012 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.012 | ||
| DPEP2 | dipeptidase 2 | 0.012 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.012 | ||
| PELI3 | pellino homolog 3 (Drosophila) | 0.012 | ||
| EREG | epiregulin | 0.012 | ||
| IRF9 | interferon regulatory factor 9 | 0.012 | Mouse | |
| BEST1 | bestrophin 1 | 0.012 | ||
| TXNDC3 | thioredoxin domain containing 3 (spermatozoa) | 0.012 | ||
| PGLYRP1 | peptidoglycan recognition protein 1 | 0.012 | ||
| C5orf13 | chromosome 5 open reading frame 13 | 0.012 | ||
| GPR183 | G protein-coupled receptor 183 | 0.012 | ||
| SGTA | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha | 0.012 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.012 | ||
| XPNPEP1 | X-prolyl aminopeptidase (aminopeptidase P) 1, soluble | 0.012 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.012 | ||
| IL3RA | interleukin 3 receptor, alpha (low affinity) | 0.012 | ||
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.012 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.012 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.012 | ||
| C5orf56 | chromosome 5 open reading frame 56 | 0.012 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.012 | ||
| CXorf21 | chromosome X open reading frame 21 | 0.012 | ||
| PVRIG | poliovirus receptor related immunoglobulin domain containing | 0.012 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.011 | ||
| NGFR | nerve growth factor receptor | 0.011 | ||
| THBD | thrombomodulin | 0.011 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.011 | ||
| CTBP2 | C-terminal binding protein 2 | 0.011 | ||
| LGALS2 | lectin, galactoside-binding, soluble, 2 | 0.011 | ||
| DOK3 | docking protein 3 | 0.011 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.011 | ||
| DOK1 | docking protein 1, 62kDa (downstream of tyrosine kinase 1) | 0.011 | ||
| IRF5 | interferon regulatory factor 5 | 0.011 | ||
| OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.011 | ||
| TRPM2 | transient receptor potential cation channel, subfamily M, member 2 | 0.011 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.011 | ||
| TAGAP | T-cell activation RhoGTPase activating protein | 0.011 | ||
| APOL3 | apolipoprotein L, 3 | 0.011 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.011 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.011 | Human | |
| KLF7 | Kruppel-like factor 7 (ubiquitous) | 0.011 | Human | |
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.011 | ||
| IL24 | interleukin 24 | 0.011 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.011 | ||
| IL2 | interleukin 2 | 0.011 | ||
| C11orf21 | chromosome 11 open reading frame 21 | 0.011 | ||
| CD226 | CD226 molecule | 0.011 | ||
| FOLR3 | folate receptor 3 (gamma) | 0.011 | ||
| PTPN4 | protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) | 0.011 | ||
| AIM2 | absent in melanoma 2 | 0.011 | ||
| C15orf39 | chromosome 15 open reading frame 39 | 0.011 | ||
| MEFV | Mediterranean fever | 0.011 | ||
| FES | feline sarcoma oncogene | 0.011 | ||
| EPX | eosinophil peroxidase | 0.011 | ||
| TLR1 | toll-like receptor 1 | 0.011 | Human Mouse | |
| TNFRSF18 | tumor necrosis factor receptor superfamily, member 18 | 0.011 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.011 | ||
| SP110 | SP110 nuclear body protein | 0.011 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.011 | Mouse | |
| PRKCQ | protein kinase C, theta | 0.011 | Mouse | |
| TXK | TXK tyrosine kinase | 0.011 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.011 | ||
| CDC42EP2 | CDC42 effector protein (Rho GTPase binding) 2 | 0.011 | ||
| SIGLEC9 | sialic acid binding Ig-like lectin 9 | 0.011 | ||
| BTLA | B and T lymphocyte associated | 0.011 | ||
| PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.011 | ||
| STK36 | serine/threonine kinase 36 | 0.011 | ||
| PDCD1LG2 | programmed cell death 1 ligand 2 | 0.011 | Human | |
| DOK2 | docking protein 2, 56kDa | 0.011 | ||
| SLAMF8 | SLAM family member 8 | 0.010 | ||
| ARL4C | ADP-ribosylation factor-like 4C | 0.010 | ||
| CD4 | CD4 molecule | 0.010 | ||
| PRKD2 | protein kinase D2 | 0.010 | ||
| EDN1 | endothelin 1 | 0.010 | ||
| SIGLEC12 | sialic acid binding Ig-like lectin 12 | 0.010 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.010 | ||
| IL12RB2 | interleukin 12 receptor, beta 2 | 0.010 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.010 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.010 | ||
| TRAF3IP2 | TRAF3 interacting protein 2 | 0.010 | ||
| MMP27 | matrix metallopeptidase 27 | 0.010 | ||
| HAS1 | hyaluronan synthase 1 | 0.010 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.010 | ||
| SP140 | SP140 nuclear body protein | 0.010 | ||
| HLA-DOB | major histocompatibility complex, class II, DO beta | 0.010 | ||
| BTN2A1 | butyrophilin, subfamily 2, member A1 | 0.010 | Human | |
| VPREB1 | pre-B lymphocyte 1 | 0.010 | ||
| EP300 | E1A binding protein p300 | 0.010 | ||
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.010 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.010 | Human | |
| PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.010 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.010 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.010 | ||
| ARHGAP25 | Rho GTPase activating protein 25 | 0.010 | ||
| CUL4A | cullin 4A | 0.010 | ||
| TLR5 | toll-like receptor 5 | 0.010 | Human |